Literature DB >> 26393020

Are sputum samples of retreatment tuberculosis reaching the reference laboratories? A 9-year audit in Tanzania.

A M Kilale1, B J Ngowi2, G S Mfinanga2, S Egwaga3, B Doulla4, A M V Kumar5, M Khogali6, J van Griensven7, A D Harries8, R Zachariah9, S G Hinderaker10.   

Abstract

SETTING: One reference and three zonal laboratories and 500 health facilities managing retreatment tuberculosis (TB) patients in Tanzania.
OBJECTIVES: The National Tuberculosis and Leprosy Programme (NTLP) requires that all notified cases of retreatment TB in Tanzania have sputum samples sent for culture and drug susceptibility testing (DST). This study determined 1) if the number of annually notified retreatment patients corresponded to the number of sputum samples received by the reference laboratories, and 2) the number of culture-positive samples and the number of cases undergoing DST.
DESIGN: Nine-year audit of country-wide programme data from 2002 to 2010.
RESULTS: Of the 40 940 retreatment TB patients notified by the NTLP, 3871 (10%) had their sputum samples received at the reference and zonal laboratories for culture and DST. A total of 3761 (97%) sputum samples were processed for culture, of which 1589 (42%) were found to be culture-positive and 1415 (89%) had DST performed.
CONCLUSIONS: There is a >90% shortfall between notified retreatment cases and numbers of sputum samples received, cultured and assessed for DST at reference and zonal laboratories. Steps needed to address this problem are discussed.

Entities:  

Keywords:  DST; Tanzania; operational research; retreatment TB; sputum

Year:  2013        PMID: 26393020      PMCID: PMC4463101          DOI: 10.5588/pha.12.0103

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  9 in total

1.  Tuberculosis 'retreatment others': profile and treatment outcomes in the state of Andhra Pradesh, India.

Authors:  S Srinath; B Sharath; K Santosha; S S Chadha; S Roopa; K Chander; F Wares; L S Chauhan; N C Wilson; A D Harries
Journal:  Int J Tuberc Lung Dis       Date:  2011-01       Impact factor: 2.373

2.  Using a bus service for transporting sputum specimens to the Central Reference Laboratory: effect on the routine TB culture service in Malawi.

Authors:  A D Harries; J Michongwe; T E Nyirenda; J R Kemp; S B Squire; A R Ramsay; P Godfrey-Faussett; F M Salaniponi
Journal:  Int J Tuberc Lung Dis       Date:  2004-02       Impact factor: 2.373

3.  National anti-tuberculosis drug resistance study in Tanzania.

Authors:  T M Chonde; D Basra; S G M Mfinanga; N Range; F Lwilla; R P Shirima; A van Deun; M Zignol; F G Cobelens; S M Egwaga; F van Leth
Journal:  Int J Tuberc Lung Dis       Date:  2010-08       Impact factor: 2.373

4.  Why ethics is indispensable for good-quality operational research.

Authors:  M Edginton; D Enarson; R Zachariah; T Reid; S Satyanarayana; K Bissell; S G Hinderaker; T Harries
Journal:  Public Health Action       Date:  2012-03-21

5.  The quality of sputum smear microscopy diagnosis of pulmonary tuberculosis in Dar es Salaam, Tanzania.

Authors:  G S Mfinanga; E Ngadaya; R Mtandu; B Mutayoba; D Basra; G Kimaro; T M Chonde; P Ngowi; S Mfaume; A M Kilale; S Egwaga; A Y Kitua
Journal:  Tanzan Health Res Bull       Date:  2007-09

6.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Ann Intern Med       Date:  2007-10-16       Impact factor: 25.391

7.  Patient-centred tuberculosis treatment delivery under programmatic conditions in Tanzania: a cohort study.

Authors:  Saidi Egwaga; Abdallah Mkopi; Nyagosya Range; Vera Haag-Arbenz; Amuri Baraka; Penny Grewal; Frank Cobelens; Hassan Mshinda; Fred Lwilla; Frank van Leth
Journal:  BMC Med       Date:  2009-12-21       Impact factor: 8.775

8.  Effect of drug resistance on the generation of secondary cases of tuberculosis.

Authors:  Marcos Burgos; Kathryn DeRiemer; Peter M Small; Philip C Hopewell; Charles L Daley
Journal:  J Infect Dis       Date:  2003-12-09       Impact factor: 5.226

9.  Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.

Authors:  Anna Vassall; Sanne van Kampen; Hojoon Sohn; Joy S Michael; K R John; Saskia den Boon; J Lucian Davis; Andrew Whitelaw; Mark P Nicol; Maria Tarcela Gler; Anar Khaliqov; Carlos Zamudio; Mark D Perkins; Catharina C Boehme; Frank Cobelens
Journal:  PLoS Med       Date:  2011-11-08       Impact factor: 11.069

  9 in total
  22 in total

1.  Promoting operational research through fellowships: a case study from the South-East Asia Union Office.

Authors:  A M V Kumar; S Satyanarayana; S Dar Berger; S S Chadha; R J Singh; P Lal; J Tonsing; A D Harries
Journal:  Public Health Action       Date:  2015-03-21

2.  Screening retreatment tuberculosis patients for drug resistance in mid-west Nepal: how well are we doing?

Authors:  M B Tharu; A D Harries; S Goel; S Srivastava; A M V Kumar; M Adhikari; B Shrestha; B Maharjan; H Khadka
Journal:  Public Health Action       Date:  2014-03-21

3.  Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe.

Authors:  K Charambira; S Ade; A D Harries; R T Ncube; C Zishiri; C Sandy; H Mutunzi; K Takarinda; P Owiti; P Mafaune; P Chonzi
Journal:  Public Health Action       Date:  2016-06-21

4.  MDR-TB in Puducherry, India: reduction in attrition and turnaround time in the diagnosis and treatment pathway.

Authors:  H D Shewade; S Govindarajan; P Thekkur; C Palanivel; M Muthaiah; A M V Kumar; V Gupta; B N Sharath; J P Tripathy; K Vivekananda; G Roy
Journal:  Public Health Action       Date:  2016-12-21

5.  Has TB CARE I sputum transport improved access to culture services for retreatment tuberculosis patients in Zimbabwe?

Authors:  C Timire; K C Takarinda; C Sandy; C Zishiri; A M V Kumar; A D Harries
Journal:  Public Health Action       Date:  2018-06-21

6.  Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India.

Authors:  H D Shewade; K S Shringarpure; M Parmar; N Patel; S Kuriya; S Shihora; N Ninama; N Gosai; R Khokhariya; C Popat; H Thanki; B Modi; P Dave; R K Baxi; A M V Kumar
Journal:  Public Health Action       Date:  2018-06-21

7.  MDR-TB screening in a setting with molecular diagnostic techniques: who got tested, who didn't and why?

Authors:  H D Shewade; S Govindarajan; B N Sharath; J P Tripathy; P Chinnakali; A M V Kumar; M Muthaiah; K Vivekananda; A K Paulraj; G Roy
Journal:  Public Health Action       Date:  2015-06-21

8.  Identifying multidrug resistance in previously treated tuberculosis patients: a mixed-methods study in Cambodia.

Authors:  S Royce; S Khann; R P Yadav; E T Mao; A Cattamanchi; S Sam; M A Handley
Journal:  Int J Tuberc Lung Dis       Date:  2014-11       Impact factor: 2.373

9.  The Multi-Drug Resistant Tuberculosis Diagnosis and Treatment Cascade in Bangladesh.

Authors:  Sarder Tanzir Hossain; Petros Isaakidis; Karuna D Sagili; Shayla Islam; Md Akramul Islam; Hemant Deepak Shewade; S M Mostofa Kamal; Ashaque Husain
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

10.  Overcoming the health system barriers to early diagnosis and management of multidrug-resistant tuberculosis in a rural setting in North India.

Authors:  Mohammad Abu Bashar; Arun Aggarwal; Sudip Bhattacharya
Journal:  BMJ Case Rep       Date:  2020-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.